AZNAX
Price
$12.33
Change
-$0.01 (-0.08%)
Updated
Jun 22 closing price
Net Assets
4.9B
RLEFX
Price
$40.73
Change
-$0.14 (-0.34%)
Updated
Jun 22 closing price
Net Assets
287.61B
Interact to see
Advertisement

AZNAX vs RLEFX

AZNAX vs RLEFX Comparison Chart in %
View a ticker or compare two or three
VS
AZNAX vs. RLEFX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZNAX is a StrongBuy and RLEFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 288B vs. AZNAX (4.91B). AZNAX pays higher dividends than RLEFX: AZNAX (2.07) vs RLEFX (1.94). AZNAX was incepted earlier than RLEFX: AZNAX (19 years) vs RLEFX (11 years). AZNAX (1.14) is less costly to investors than RLEFX (0.39). AZNAX is a more actively managed with annual turnover of: 76.00 vs. RLEFX (50.00). RLEFX has a lower initial minimum investment than AZNAX: RLEFX (250) vs AZNAX (2500). RLEFX annual gain was more profitable for investors over the last year : 16.92 vs. AZNAX (14.45). RLEFX return over 5 years is better than : 37.16 vs. AZNAX (4.30).
AZNAXRLEFXAZNAX / RLEFX
Total Expense Ratio1.140.39292%
Annual Report Gross Expense Ratio1.140.39292%
Fund Existence19 years11 years-
Gain YTD7.4669.45779%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.91B288B2%
Annual Yield % from dividends2.071.94107%
Returns for 1 year14.4516.9285%
Returns for 3 years26.4245.1259%
Returns for 5 years4.3037.1612%
Returns for 10 years42.4492.2046%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APRE0.790.08
+11.06%
Aprea Therapeutics
BIIB199.713.13
+1.59%
Biogen
CPRX31.390.01
+0.03%
Catalyst Pharmaceuticals
ESPR3.15N/A
N/A
Esperion Therapeutics
BZUN2.72-0.06
-2.33%
Baozun